Chinese english Germany Japanese Korea

Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)-

Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)- Struktur
119328-63-1
CAS-Nr.
119328-63-1
Englisch Name:
Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)-
Synonyma:
Vecuronium Bromide Impurity 3;Vecuronium Bromide Impurity 15;Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)-
CBNumber:
CB68088264
Summenformel:
C29H50N2O2
Molgewicht:
458.73
MOL-Datei:
119328-63-1.mol
Request For Quotation

Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)- Eigenschaften

Siedepunkt:
571.1±50.0 °C(Predicted)
Dichte
1.117±0.06 g/cm3(Predicted)
pka
14.91±0.70(Predicted)

Sicherheit

Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 8046 55
Jinan blalong chemical co. LTD 2710913286@.com
 1513643261@qq.com China 14253 58
Guangzhou Juntang Technology Co., Ltd 020-36607679 13502246435
 sales@dmstandards.com China 10951 58
Shanghai Zerui Biotechnology Co., Ltd. 021-54580889 18321124657
 731997554@qq.com China 10614 58

119328-63-1()Verwandte Suche:

Pancuroniumbromid (2β,3α,5α,16β,17β)-2,16-Dipiperidin-1-ylandrosta-3,17diol 3β-Hydroxy-2β,16β-dipiperidino-5-α-androstan-17-one
  • Androstane-3,17-diol, 2,16-di-1-piperidinyl-, (2β,3α,5α,16β,17α)-
  • Vecuronium Bromide Impurity 3
  • Vecuronium Bromide Impurity 15
  • 119328-63-1
Copyright 2019 © ChemicalBook. All rights reserved